These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33872329)

  • 1. Mechanisms of HIV-1 evasion to the antiviral activity of chemokine CXCL12 indicate potential links with pathogenesis.
    Armani-Tourret M; Zhou Z; Gasser R; Staropoli I; Cantaloube-Ferrieu V; Benureau Y; Garcia-Perez J; Pérez-Olmeda M; Lorin V; Puissant-Lubrano B; Assoumou L; Delaugerre C; Lelièvre JD; Lévy Y; Mouquet H; Martin-Blondel G; Alcami J; Arenzana-Seisdedos F; Izopet J; Colin P; Lagane B
    PLoS Pathog; 2021 Apr; 17(4):e1009526. PubMed ID: 33872329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
    Tu CC; Arnolds KL; O'Connor CM; Spencer JV
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis of bystander T cells induced by human immunodeficiency virus type 1 with increased envelope/receptor affinity and coreceptor binding site exposure.
    Holm GH; Zhang C; Gorry PR; Peden K; Schols D; De Clercq E; Gabuzda D
    J Virol; 2004 May; 78(9):4541-51. PubMed ID: 15078935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions.
    Holm GH; Gabuzda D
    J Virol; 2005 May; 79(10):6299-311. PubMed ID: 15858014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of chemokine receptors CCR5 and CXCR4 on CD4+ T cells and plasma chemokine levels during treatment of active tuberculosis in HIV-1-coinfected patients.
    Wolday D; Tegbaru B; Kassu A; Messele T; Coutinho R; van Baarle D; Miedema F
    J Acquir Immune Defic Syndr; 2005 Jul; 39(3):265-71. PubMed ID: 15980685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies.
    Nabatov AA; Pollakis G; Linnemann T; Kliphius A; Chalaby MI; Paxton WA
    J Virol; 2004 Jan; 78(1):524-30. PubMed ID: 14671134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4+ T cells.
    Costantino CM; Gupta A; Yewdall AW; Dale BM; Devi LA; Chen BK
    PLoS One; 2012; 7(3):e33961. PubMed ID: 22448282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo.
    Glushakova S; Yi Y; Grivel JC; Singh A; Schols D; De Clercq E; Collman RG; Margolis L
    J Clin Invest; 1999 Sep; 104(5):R7-R11. PubMed ID: 10487781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The implication of the chemokine receptor CXCR4 in HIV-1 envelope protein-induced apoptosis is independent of the G protein-mediated signalling.
    Blanco J; Jacotot E; Cabrera C; Cardona A; Clotet B; De Clercq E; Esté JA
    AIDS; 1999 May; 13(8):909-17. PubMed ID: 10371171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pairwise comparison of isogenic HIV-1 viruses: R5 phenotype replicates more efficiently than X4 phenotype in primary CD4+ T cells expressing physiological levels of CXCR4.
    Fiser AL; Lin YL; Portalès P; Mettling C; Clot J; Corbeau P
    J Acquir Immune Defic Syndr; 2010 Feb; 53(2):162-6. PubMed ID: 20051874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use.
    Schols D; Esté JA; Cabrera C; De Clercq E
    J Virol; 1998 May; 72(5):4032-7. PubMed ID: 9557691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance against syncytium-inducing human immunodeficiency virus type 1 (HIV-1) in selected CD4(+) T cells from an HIV-1-infected nonprogressor: evidence of a novel pathway of resistance mediated by a soluble factor(s) that acts after virus entry.
    Saha K; Volsky DJ; Matczak E
    J Virol; 1999 Sep; 73(9):7891-8. PubMed ID: 10438887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal analysis of subtype C envelope tropism for memory CD4
    Gartner MJ; Gorry PR; Tumpach C; Zhou J; Dantanarayana A; Chang JJ; Angelovich TA; Ellenberg P; Laumaea AE; Nonyane M; Moore PL; Lewin SR; Churchill MJ; Flynn JK; Roche M
    Retrovirology; 2020 Aug; 17(1):24. PubMed ID: 32762760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation.
    Vicenzi E; Bordignon PP; Biswas P; Brambilla A; Bovolenta C; Cota M; Sinigaglia F; Poli G
    J Virol; 1999 Sep; 73(9):7515-23. PubMed ID: 10438841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1.
    Pierson T; Hoffman TL; Blankson J; Finzi D; Chadwick K; Margolick JB; Buck C; Siliciano JD; Doms RW; Siliciano RF
    J Virol; 2000 Sep; 74(17):7824-33. PubMed ID: 10933689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue.
    Penn ML; Grivel JC; Schramm B; Goldsmith MA; Margolis L
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):663-8. PubMed ID: 9892690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evolution of human immunodeficiency virus type 1 toward increased pathogenicity through CXCR4-mediated killing of uninfected CD4 T cells.
    Jekle A; Keppler OT; De Clercq E; Schols D; Weinstein M; Goldsmith MA
    J Virol; 2003 May; 77(10):5846-54. PubMed ID: 12719578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential cytolysis of peripheral memory CD4+ T cells by in vitro X4-tropic human immunodeficiency virus type 1 infection before the completion of reverse transcription.
    Zhou Y; Shen L; Yang HC; Siliciano RF
    J Virol; 2008 Sep; 82(18):9154-63. PubMed ID: 18596085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 coreceptor usage, transmission, and disease progression.
    Philpott SM
    Curr HIV Res; 2003 Apr; 1(2):217-27. PubMed ID: 15043204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymic pathogenicity of an HIV-1 envelope is associated with increased CXCR4 binding efficiency and V5-gp41-dependent activity, but not V1/V2-associated CD4 binding efficiency and viral entry.
    Meissner EG; Coffield VM; Su L
    Virology; 2005 Jun; 336(2):184-97. PubMed ID: 15892960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.